Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

News headlines Vertex Pharmaceuticals (VRTX) is gaining traction with strong kidney data and regulatory advancements for its drug povetacicept. The company has raised its revenue guidance for 2025, ...